Home / Treatments / Residential Treatment Center Level 3.1
Residential Treatment Center Level 3.1 denials: what the review data shows
Independent reviewers have decided 14 published cases where an insurer denied Residential Treatment Center Level 3.1 — and they overturned the insurer 85.7% of the time. A denial for Residential Treatment Center Level 3.1 is a starting position, not a final answer.
Published decisions
14
2001–2026
Overturned
85.7%
12 denials reversed
Conditions behind residential treatment center level 3.1 denials
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Opioid Use Disorder | 7 | 100% |
| Depression | 4 | 100% |
| Alcohol Use Disorder | 4 | 100% |
| Substance Use Disorder | 3 | 33.3% |
| Post-traumatic Stress Disorder | 3 | 100% |
Typical time to a decision
6 days
Most land between 5 and 19 days
Handled as urgent
78.6%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) (ASAM 3.1) level of care. Findings: The physician reviewer found that Per the American Society of Addiction Medicine (ASAM) criteria, this patient meets Level 3.1 criteria for RTC services for the time period under review. For Dimension 1, the patient’s intoxication and associated risk, withdrawal and associated risks, and addiction medication needs should be discussed and scored. The medical records indicated that the patient had moderate-severe symptoms of withdrawal from both opiates and benzodiazepines. The patient’s universal urine toxicology on admission was positive for fentanyl, methamphetamine, and benzodiazepines.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for all or any of the residential treatment center (RTC) services, specifically ASAM level 3.1. Per American Society of Addiction Medicine (ASAM) criteria, this patient met Level 3.1 criteria for RTC services. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient has a history of seizures during opiate withdrawal in the past. She does not have acute symptoms of withdrawal. The patient’s withdrawal needs were safely managed in a Level 3.1 setting.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) services, specifically ASAM level 3.1. ASAM criteria focus on six dimensions to determine the appropriate level of care, which includes: (1)intoxication and withdrawal potential; (2)biomedical conditions; (3)emotional, behavioral, and cognitive conditions; (4)readiness to change; (5)relapse, continued use, or continued problem potential; and (6)recovery environment. According to the ASAM criteria, the patient does not meet level 3.1 criteria for RTC services.For dimension 1, the patient did not have any symptoms of acute withdrawal after completing detoxification services and was being treated in level 3.1 RTC.
Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) (ASAM 3.1) level of care. Per the American Society of Addiction Medicine (ASAM) criteria, this patient does not meet Level 3.1 criteria for RTC services for the time period under review. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and associated risk, withdrawal and associated risks, and addiction medication needs; (2) biomedical conditions including physical health concerns and pregnancy-related concerns; (3) psychiatric and cognitive conditions and history including active psychiatric symptoms and persistent disability; (4) substance use-related risks including the likelihood of engaging in risky substance use and the likelihood of engaging in risky subs…
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Residential Treatment Center Level 3.1when you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.